SINGAPORE (Nov 19): Healthcare provider Religare Health Trust is “fairly priced” at $0.97, with the firm’s expansionary outlook now included in its current valuation, DBS says in a note.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply